This course has expired. View available courses.
Infectious Disease
Pharmacist-led flu vaccinations in adults 65 years and over: challenges and strategies – The Australian Pharmacy Council
Seasonal influenza (flu) is an acute respiratory infection which can affect up to 20% of the general community each year. Older adults who become infected with the flu are at a significantly elevated risk of complications compared to adults of a younger age. Complications can include secondary bacterial infections such as pneumonia, sinusitis and otitis media, as well as conditions related to ischaemic cardiomyopathy, cerebrovascular disease and diabetes. Hospitalisation and death due to influenza infection is also more common among high-risk groups. Most deaths associated with influenza in countries like Australia occur among individuals who are 65 years of age or older.The most important prevention measure for influenza and its complications is yearly vaccination. Australian immunisation guidelines currently recommend one annual dose of influenza vaccination for people aged 65 years and over. Vaccinating older adults can reduce the severity of disease, the rate of hospitalisation from influenza and pneumonia, and all-cause mortality.
DURATION
1 hr
PROFESSION
Pharmacy
# OF CREDITS
2
ACCREDITATION
EXPIRY DATE
2020-06-25
Seasonal influenza (flu) is an acute respiratory infection which can affect up to 20% of the general community each year. Older adults who become infected with the flu are at a significantly elevated risk of complications compared to adults of a younger age. Complications can include secondary bacterial infections such as pneumonia, sinusitis and otitis media, as well as conditions related to ischaemic cardiomyopathy, cerebrovascular disease and diabetes. Hospitalisation and death due to influenza infection is also more common among high-risk groups. Most deaths associated with influenza in countries like Australia occur among individuals who are 65 years of age or older.The most important prevention measure for influenza and its complications is yearly vaccination. Australian immunisation guidelines currently recommend one annual dose of influenza vaccination for people aged 65 years and over. Vaccinating older adults can reduce the severity of disease, the rate of hospitalisation from influenza and pneumonia, and all-cause mortality.
Faculty
Anthony Tassone
BPharm(Hons), AACPA, GAICD
Pharmacist
President, Pharmacy Guild of Australia, Victoria Branch, Melbourne
Learning objectives
After completing this education, pharmacists will be better able to:
- Demonstrate an understanding of the challenges facing older adults with influenza vaccination particularly immunosenescence, the H3N2 strain and its tendency to undergo antigenic drift
- Describe the mechanism of action, efficacy and safety of enhanced influenza vaccines in the population 65 years and over
- Differentiate between the standard quadrivalent influenza vaccines (QIVs) and enhanced trivalent influenza vaccines and which vaccine is recommended in specific age groups
Accreditation
#
of credits: 2
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Pharmacy
Profession
2
# of credits
Learning Objectives
After completing this education, pharmacists will be better able to:
- Demonstrate an understanding of the challenges facing older adults with influenza vaccination particularly immunosenescence, the H3N2 strain and its tendency to undergo antigenic drift
- Describe the mechanism of action, efficacy and safety of enhanced influenza vaccines in the population 65 years and over
- Differentiate between the standard quadrivalent influenza vaccines (QIVs) and enhanced trivalent influenza vaccines and which vaccine is recommended in specific age groups
ACCREDITATION
Infectious Disease
Learning Category
General
Topic
0
Price
2020-06-25
Expiry Date
AUS
Region/Language
Course Description
Seasonal influenza (flu) is an acute respiratory infection which can affect up to 20% of the general community each year. Older adults who become infected with the flu are at a significantly elevated risk of complications compared to adults of a younger age. Complications can include secondary bacterial infections such as pneumonia, sinusitis and otitis media, as well as conditions related to ischaemic cardiomyopathy, cerebrovascular disease and diabetes. Hospitalisation and death due to influenza infection is also more common among high-risk groups. Most deaths associated with influenza in countries like Australia occur among individuals who are 65 years of age or older.The most important prevention measure for influenza and its complications is yearly vaccination. Australian immunisation guidelines currently recommend one annual dose of influenza vaccination for people aged 65 years and over. Vaccinating older adults can reduce the severity of disease, the rate of hospitalisation from influenza and pneumonia, and all-cause mortality.
Faculty
Anthony Tassone
BPharm(Hons), AACPA, GAICD
Pharmacist
President, Pharmacy Guild of Australia, Victoria Branch, Melbourne
Accreditation
This activity has been accredited for 1.00 hour(s) of Group 2 CPD (or 2 CPD Credits) suitable for inclusion in an individual pharmacist’s CPD plan
1 hr
Duration
0
Price
2
# of credits
